2m 2m 2m 2m 2m 2m 2m
Strata Critica-A (SRTA)
NASDAQ
$5.57-$0.18 (-3.22%)
Price as of Jun 23, 2026 4:48 PM EDT- $497.5MMarket Cap
- N/A1-Year Change
- Medical Care FacilitiesIndustry
Strata Critica-A (SRTA)
$5.57-$0.18 (-3.22%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 197.1M -20.73% | 248.7M +10.44% | 225.2M +54.11% | 146.1M +189.20% | |
Cost of Revenue | 156.0M -17.79% | 189.8M +3.67% | 183.1M +47.81% | 123.8M +211.79% | |
Gross Profit | 41.1M -30.20% | 58.9M +39.88% | 42.1M +89.10% | 22.3M +106.15% | |
Sales and Marketing Expense | 60.9M +665.72% | 8.0M -23.84% | 10.4M +34.70% | 7.7M +123.83% | |
Research and Development Expense | N/A N/A | -3.2M -31.19% | -4.6M -16.56% | -5.5M +266.25% | |
Depreciation and Amortization Expense | 8.2M +37.29% | 6.0M -16.16% | 7.1M +24.21% | 5.7M +860.57% | |
Total Operating Expenses | 63.5M -77.54% | 282.6M -3.64% | 293.3M +46.91% | 199.6M +167.56% | |
Operating Profit | -22.4M -34.11% | -33.9M -50.19% | -68.1M +27.25% | -53.5M +122.18% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | 2.3M -64.06% | 6.4M -39.82% | 10.6M -58.52% | 25.5M +230.07% | |
Income before Taxes | -20.1M -27.20% | -27.6M -52.10% | -57.5M +105.27% | -28.0M -35.85% | |
Income Taxes | 0 +100.00% | -255,000 -82.61% | -1.5M +89.90% | -772,000 -78.81% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 41.3M +251.42% | -27.3M -51.30% | -56.1M +105.71% | -27.3M -31.94% | |
Net Income from Continuing Operations Applicable to Common | -20.1M -27.20% | -27.6M -52.10% | -57.5M +105.27% | -28.0M -35.85% | |
Basic EPS and Net Income | 0.50 +242.86% | -0.35 -53.95% | -0.76 +100.00% | -0.38 -59.14% | |
Diluted EPS and Net Income | 0.50 +242.86% | -0.35 -53.95% | -0.76 +100.00% | -0.38 -59.14% | |
Basic Weighted Average Shares | 82.1M +5.93% | 77.5M +5.41% | 73.5M +3.21% | 71.2M +66.12% | |
Diluted Weighted Average Shares | 82.1M +5.93% | 77.5M +5.41% | 73.5M +3.21% | 71.2M +66.12% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 31.0M +68.51% | 18.4M -34.07% | 27.9M -35.62% | 43.3M +522.78% | |
Short-Term Investments | 30.3M -72.17% | 108.8M -21.34% | 138.3M -8.28% | 150.7M -49.28% | |
Cash and Cash Equivalents and Short-Term Investments | 61.2M -51.84% | 127.1M -23.48% | 166.1M -14.38% | 194.0M -36.20% | |
Total Current Assets | 126.2M -21.49% | 160.7M -22.07% | 206.3M -5.44% | 218.1M -30.63% | |
Accumulated Depreciation | 6.3M +18.67% | 5.3M +67.89% | 3.2M +41.23% | 2.2M +55.14% | |
Property and Plant and Equipment and Net | 36.4M +17.87% | 30.9M +966.51% | 2.9M +42.32% | 2.0M +4.03% | |
Total Long-Term Assets | 24.0M +1,572.49% | 1.4M +2.43% | 1.4M +44.54% | 970,000 +340.91% | |
Total Assets | 325.5M +26.80% | 256.7M -12.97% | 294.9M -9.26% | 325.0M -5.35% | |
Income Taxes Payable | 348,000 +88.11% | 185,000 -58.98% | 451,000 -75.96% | 1.9M +862.05% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 19.8M -12.90% | 22.7M -35.97% | 35.5M +33.39% | 26.6M +179.16% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Total Long-Term Liabilities | 22.1M +80.99% | 12.2M -52.36% | 25.6M -0.80% | 25.8M -39.75% | |
Total Liabilities | 46.4M +33.58% | 34.7M -42.71% | 60.6M +19.99% | 50.5M -3.12% | |
Retained Earnings | -145.6M -22.12% | -186.9M +16.99% | -159.8M +54.09% | -103.7M +34.32% | |
Total Stockholders Equity | 279.1M +25.74% | 221.9M -5.28% | 234.3M -14.64% | 274.5M -5.75% | |
Total Shares Outstanding | 86.7M +9.17% | 79.4M +5.71% | 75.1M +4.84% | 71.7M +2.23% | |
Cash Flow | |||||
Cash from Operating Activities | -48.9M +1,841.80% | -2.5M -92.21% | -32.3M -12.88% | -37.1M +137.78% | |
Capital Expenditures | 9.6M -68.92% | 30.9M +1,363.96% | 2.1M +188.90% | 730,000 +145.79% | |
Cash from Investing Activities | 69.8M +6,965.16% | -1.0M -105.95% | 17.1M -78.46% | 79.3M +124.69% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -8.9M +54.75% | -5.8M +7,477.63% | -76,000 -92.99% | -1.1M -100.33% | |
Financials Ratio | |||||
Gross Margin | 20.86% -11.95% | 23.69% +26.65% | 18.71% +22.71% | 15.24% -28.71% | |
Operating Margin | -11.34% -16.88% | -13.64% -54.90% | -30.25% -17.43% | -36.63% -23.17% | |
Return on Assets | 14.21% +243.47% | -9.90% -45.27% | -18.09% +121.78% | -8.16% -36.74% | |
Return on Equity | 16.51% +237.88% | -11.97% -45.69% | -22.04% +128.72% | -9.64% -64.36% | |
Revenue Growth | -20.73% -298.52% | 10.44% -80.70% | 54.11% -71.40% | 189.20% N/A | |
Current Ratio | 6.38 -9.86% | 7.07 +21.70% | 5.81 -29.11% | 8.20 -75.15% | |
Cash Ratio | 1.56 +93.46% | 0.81 +2.97% | 0.79 -51.73% | 1.63 +123.09% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow